Safety and Efficacy of a Pentavalent Human–Bovine (WC3) Reassortant Rotavirus Vaccine

New England Journal of Medicine - Tập 354 Số 1 - Trang 23-33 - 2006
Timo Vesikari1, David O. Matson2, Penelope H. Dennehy3, Pierre Van Damme4,3, Mathuram Santosham5, Zoe Rodriguez6, Michael J. Dallas7, Joseph F. Heyse7, Michelle G. Goveia7, Steven Black8, Henry R. Shinefield9, C D C Christie10, Samuli Ylitalo1, Robbin Itzler7, Michele L. Coia7, Matthew T. Onorato7, Ben Adeyi7, Gary S. Marshall11, Leif Gothefors12, Dirk Campens13, Aino Karvonen1, James Watt5, Katherine L. O’Brien5, Mark J. DiNubile7, H. F. Clark, John W. Boslego7, Paul A. Offit14, Penny M. Heaton7
1University of Tampere Medical School, Tampere, Finland
2Center for Pediatric Research, Eastern Virginia Medical School, Norfolk
3Division of Pediatric Infectious Diseases, Rhode Island Hospital, Providence
4Center for the Evaluation of Vaccination, University of Antwerp, Antwerp, Belgium
5Center for American Indian Health, Department of International Health, Johns Hopkins University Bloomberg School of Public Health, Baltimore
6University of Puerto Rico School of Medicine, San Juan
7Merck Research Laboratories, West Point, PA
8Kaiser Permanente Vaccine Study Center, Oakland, Calif
9Institute of Vaccine and Pharmacologic Research in San Francisco, San Francisco
10Department of Pediatrics, University of the West Indies, Kingston, Jamaica
11Department of Pediatrics, University of Louisville School of Medicine, Louisville, KY
12Department of Clinical Sciences, Pediatrics, Umea University, Umea, Sweden
13Sanofi Pasteur Merck, Sharp & Dohme, Lyon, France
14Children's Hospital and the University of Pennsylvania School of Medicine, Philadelphia

Tóm tắt

Từ khóa


Tài liệu tham khảo

10.3201/eid0905.020562

10.1016/S0264-410X(98)00376-4

10.1086/314504

10.1093/infdis/169.3.504

10.1056/NEJM199610033351404

10.1086/317619

10.1093/infdis/174.Supplement_1.S30

10.1002/rmv.448

1999, MMWR Recomm Rep, 48, 1

1999, MMWR Morb Mortal Wkly Rep, 48, 577

Kramarz P, 2001, Pediatr Infect Dis J, 204, 10

10.1056/NEJM200102223440804

10.1542/peds.106.6.1413

10.1542/peds.110.6.e67

10.1542/peds.113.4.e353

10.1016/S0140-6736(97)05118-0

10.1097/00006454-199804000-00013

Rennels MB, 1996, Pediatrics, 97, 7

1999, MMWR Morb Mortal Wkly Rep, 48, 1007

10.3928/0090-4481-20040801-11

10.1016/S0140-6736(04)16155-2

10.1016/j.jpeds.2003.10.054

Vesikari T, Clark HF, Offit PA, et al. The effect of dose and composition of a pentavalent rotavirus vaccine (RotaTeq) upon safety, efficacy, and immunogenicity in healthy infants. Presented at the 22nd annual meeting of the European Society for Pediatric Infectious Diseases (ESPID), Tampere, Finland, May 26–28, 2004.

10.1097/00006454-200202000-00003

10.1097/00006454-199810000-00018

10.1086/431500

10.1016/0732-8893(87)90053-8

Dolan KT, 1985, J Clin Microbiol, 21, 753, 10.1128/JCM.21.5.753-758.1985

Jennison C, Turnbull BW. Group sequential methods with applications to clinical trials. Boca Raton, Fla.: Chapman & Hall/CRC, 2000.

10.1128/JCM.43.12.5876-5880.2005

1997, MMWR Morb Mortal Wkly Rep, 46, 1092

10.1001/jama.1990.03450080069033

10.1111/j.1651-2227.1999.tb14322.x

10.2105/AJPH.76.3.259

10.1086/514076

Coffin SE, 1997, J Virol, 71, 7851, 10.1128/JVI.71.10.7851-7856.1997

10.1016/S0140-6736(78)91339-9

Thông tin
Thông tin xuất bản

New England Journal of Medicine

Tập 354 Số 1

23-33

Thông tin tác giả